Article Detail - JE Part B
Billing and Coding: MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells (A58183) - R3 - Effective June 02, 2022
This Billing and Coding Article has been revised and published for notice under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV).
Effective Date: June 02, 2022
Summary of Article Changes:
Under ICD-10 Codes that Support Medical Necessity Group 1 typographical error regarding removal of C50.819 retroactive for dates of service on or after 07/25/2021.
Visit the Molecular Diagnostic Services (MolDX) webpage to access the MolDX Medicare Coverage Article from the “Covered Tests” or the “Excluded Tests” webpage.
To view the complete listing of coverage articles and/or access the Active, Future, or Retired articles available in the CMS MCD, visit the Medicare Coverage Articles webpage.
Last Updated Fri, 29 Jul 2022 14:16:15 +0000